|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Patento numeris | 3193934 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15779060.1 |
| Europos patento paraiškos padavimo data | 2015-09-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/050291 |
| Data | 2015-09-15 |
| (87) | Numeris | WO 2016/044343 |
| Data | 2016-03-24 |
| (30) | Numeris | Data | Šalis |
| 14306427 | 2014-09-16 | EP |
| (72) |
JOSEPH, George Johny , US
VAN HOOGSTRATEN, Hubert , US
CHEN, Chieh-I , US
FAN, Chungpeng , US
GRAHAM, Neil , US
MOMTAHEN, Tanya Marie , US
GENOVESE, Mark , US
|
| (73) |
Sanofi Biotechnology ,
54 rue La Boétie, 75008 Paris,
FR
Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591, US |
| (54) | COMPOSITIONS FOR IMPROVING THE HEALTH RELATED QUALITY OF LIFE OF RHEUMATOID ARTHRITIS PATIENTS |
| COMPOSITIONS FOR IMPROVING THE HEALTH RELATED QUALITY OF LIFE OF RHEUMATOID ARTHRITIS PATIENTS |